Eric Richman

Insider Reports History

Entity
Individual
Location
C/O Rev Capital II, Llc, 9740 Sorrel Ave, Potomac, MD
Signature
/s/ Eric Richman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Richman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Gain Therapeutics, Inc. Director Common Stock 290K $1.12M $3.86 Jul 1, 2024 Direct
Gain Therapeutics, Inc. Director Common Stock 14.8K $57.2K $3.86 Jul 1, 2024 By Trust
NeuBase Therapeutics, Inc. Director Stock option (right to buy) 37.6K Sep 9, 2022 Direct
Gain Therapeutics, Inc. Director Stock Option (right to buy) 15K Jun 24, 2024 Direct
Gain Therapeutics, Inc. Director Restricted Stock Units 0 $2.50 Sep 20, 2023 Direct

Insider Reports Filed by Eric Richman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GANX Gain Therapeutics, Inc. Jul 1, 2024 2 $20.7K 4 Jul 1, 2024 Director
GANX Gain Therapeutics, Inc. Jun 24, 2024 1 $0 4 Jun 26, 2024 Director
GANX Gain Therapeutics, Inc. Sep 20, 2023 2 $0 4 Sep 22, 2023 Director
GANX Gain Therapeutics, Inc. Sep 20, 2022 2 $0 4 Sep 22, 2022 Director
NBSE NeuBase Therapeutics, Inc. Sep 9, 2022 1 $0 4 Sep 12, 2022 Director
GANX Gain Therapeutics, Inc. May 25, 2022 1 $6.4K 4 May 27, 2022 CHIEF EXECUTIVE OFFICER, Director
GANX Gain Therapeutics, Inc. May 19, 2022 2 $37K 4 May 23, 2022 CHIEF EXECUTIVE OFFICER, Director
NBSE NeuBase Therapeutics, Inc. Mar 1, 2022 3 $6.35K 4 Mar 7, 2022 Director
NBSE NeuBase Therapeutics, Inc. Aug 19, 2021 1 $0 4 Sep 17, 2021 Director
GANX Gain Therapeutics, Inc. Aug 16, 2021 1 $38.7K 4/A Apr 21, 2022 Chief Executive Officer, Director
GANX Gain Therapeutics, Inc. Mar 17, 2021 0 $0 3/A Apr 21, 2022 Chief Executive Officer, Director